Vivo Opportunity Fund Holdings, L.P. - 01 Dec 2025 SCHEDULE 13G Report for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share
Symbol
KTTA
Shares outstanding
176M shares
Disclosed Ownership
17.6M shares
Ownership
9.99%
Form type
SCHEDULE 13G
Filing time
05 Dec 2025, 16:00:24 UTC
Date of event
01 Dec 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 9.99% 17.6M 17.6M 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 9.99% 17.6M 17.6M 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 9.99% 1.77M 1.77M 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 9.99% 1.77M 1.77M 0 /s/ Kevin Dai Kevin Dai/Managing Member